Energetics of nutrition and polyamine-related tumor growth alterations in experimental cancer. by Westin, T. et al.
Br. J. Cancer (1993), 68, 662 667
© Macmillan
Energetics of nutrition and polyamine-related tumour growth alterations
in experimental cancer
T. Westin', B. Soussi2, J.-P. Idstrdm2, P. Lindnerl, S. Edstrom', E. Lyden%, B. Gustavsson',
L. Hafstrom' & K. Lundholm'
'Departments ofOtolaryngology and Surgery Sahtgrenska Hospital, University ofGoteborg and Department ofCytology,
Linkoping University, Sweden; 2Bioenergetics Group, NMR-Unit, Department ofSurgery, University ofGoteborg, Sweden.
Summary The aim of this study was to evaluate whether food intake modulates experimental tumour growth
by acute alterations in the energy state and blood flow of the tumour, and if so whether such changes are
related to alterations in the enzyme ornithinedecarboxylase (ODC) and DNA synthesis. Inbred mice (C57BL/
J) bearing a syngeneic undifferentiated and rapidly growing tumour were used. The tumour levels of high
energy phosphates were measured in vivo by 31-P-NMR spectroscopy and biochemically following tissue
extraction. DNA synthesis was estimated by measuring the incorporation of bromodeoxy-uridine into tumour
DNA. Difluoro-methylornithine (DFMO) was used to inhibit ODC-activity. Tumour blood flow was estimated
by a '32Xe local clearance technique.
Tumour progression was associated with a significant decrease in tumour tissue high energy phosphates.
Acute starvation decreased DNA-synthesis and tumour energy charge as well as its PCr/Pi which were rapidly
normalised during subsequent refeeding. These changes were related to similar alterations in tumour blood
flow. The inorganic phosphate (Pi) resonance and the resonances in the phosphomonoester (PME) region were
considerably increased in tumour tissue. Inhibition of ODC-activity by DFMO decreased DNA-synthesis,
which was associated with a secondary increase in tumour high energy phosphates probably due to a lowered
energy demand for tumour cell division.
The results demonstrate that host undernutrition was translated into retarded tumour growth associated
with a decrease in the energy state and blood flow of the tumour. The results have bearing for the evaluation
and planning of all treatment protocols with potential influence on food intake in experimental tumour-
bearing animals.
It is well known that DNA synthesis in malignant tumours is
influenced by many factors, such as polyamines, growth fac-
tors, classical hormones, metabolites and drugs. It has been
less recognised that nutrition and food intake is one of the
most powerful modulators of tumour growth in various ex-
perimental systems (Torosian et al., 1984; Stragand et al.,
1978; Sauer et al., 1986; Popp et al., 1981; Eden et al., 1983).
Short periods of starvation, 12-24 h, will influence the
growth curve in many solid tumours. This mechanism is
important to understand, since 'therapeutical interventions'
with drugs and cytokines, promoting anorexia, might then be
misinterpreted to represent a more direct tumour influence.
In line with this we recently concluded that factors interfering
with the glucose homeostasis in tumour-bearing hosts can
indirectly control tumour cell proliferation. This conclusion
was also supported by the finding that the carbohydrate
component in ordinary animal food pellets was a powerful
stimulant of tumour cell proliferation by activating DNA
synthesis, an effect which may be evoked by insulin (Westin
et al., 1991a; Westin et al., 1991b). Changes in tumour DNA
synthesis was reflected by alterations in ornithinedecarboxy-
lase activity (ODC), which is rate limiting for polyamine
synthesis (Russel, 1973; Pegg, 1988; Ota et al., 1984; Janne et
al., 1978). Polyamines are probably endogenously produced
growth factors, that without cell DNA synthesis and cell-
cycle traverse cannot proceed normally. Thus, up- and down-
regulation of ODC-activity was intimately related to tumour
DNA synthesis, indirectly controlled by components in the
food (Westin et al., 1991a). The understanding of these
mechanisms is only in its infancy. Therefore, the aim of this
study was to evaluate to what extent food intake, acute
starvation and alterations in tumour polyamines modulate
tumour growth by acute alterations in the energy state of the
tumour.
Material and methods
Animal model
Sex matched male and female mice (C57BI/6J) were used. All
experiments were performed in 3 months old, weight-stable
mice (20-25 g). A low- to undifferentiated tumour (MCG
101), originally induced as a sarcoma by methylcholanthrene,
was used as a transplantable syngeneic tumour graft. The
tumour tissue was implanted subcutaneously in the flank by
a trocar. This tumour does not metastasise when implanted
subcutaneously and its influence on the host has been
reported elsewhere (Edstrom et al., 1985; Lundholm et al.,
1978; Lundholm et al., 1980). Whole body energy expen-
diture is increased in these tumour-bearing mice accounting
for decreased food intake, but body temperature is normal
(Lindmark et al., 1983). Histological evaluation of tumour
tissue, judged as being 'non-necrotic', has demonstrated a
rather homogeneous capillary supply without areas of dead
and lysed cells. The survival time of the tumour-bearing
animals housed at + 25°C is 15-17 days and the cause of
death has been evaluated elsewhere (Svaninger et al.,
1989).
The animals were kept in individual cages. They had free
access to tap water and purina chow (Ewos, Astra,
Sodertalje, Sweden), deficient in polyamines and with
metabolisable energy of 13.0 MJ kg-' = 3.1 Mcal kg-'. Food
intake (Lundholm et al., 1980), changes in host body com-
position (Eden et al., 1983) and tumour-growth rate (Karl-
berg et al., 1981) have been reported. The animals were killed
by cervical dislocation. In all experiments study and corres-
ponding control animals were analysed at the same time and
under identical conditions. Animals were lightly anaesthetised
by i.p. injection of pentobarbital 0.06 mg g-' when necessary
for the in vivo 3'P-NMR experiments. This procedure did not
influence tumour blood flow evaluated in separate
experiments. Blood flow measurements were performed with
a '32Xe clearance technique (Mattsson et al., 1980).
Nuclear magnetic resonance spectroscopy (3'P-NMR)
In vivo nuclear magnetic resonance spectroscopy was per-
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formed on a Bruker Biospec, BMT 24/30 at 2.35T giving an
operating frequency of 40.55 MHz for phosphorus nuclei.
The homogeneity of the magnetic field was optimised for
each individual tumour and was accepted when the half-
width of the 'H signal was <0.5 ppm for one FID. Spectra
were obtained by accumulating 128 alternatively 256 FIDs
with a repetition rate of 1 s and a radio frequency pulse
length of 75 ,is (600 flip angle). Correction for the phos-
phorus resonances was made by the use of a pulse repetition
rate of 16 s. The anaesthetised mice were placed with the
tumour in a Helmholtz coil, 2 cm diameter. The relative
concentrations of phosphocreatine (PCr), inorganic phos-
phate (Pi), phosphomonoesters (PME), phosphodiesters
(PDE) and nucleotide triphosphate (NTP) were estimated
from the computer integrated peak areas divided by the total
phosphorus area (i.e. PCr + Pi + PME + PDE + a, P, y-NTP)
(Soussi et al., 1990). The P-NTP resonance has the largest
contribution from the P-adenosine triphosphate (,B-ATP),
(k 70%), it was therefore taken as a representative of the
relative estimate of P-ATP content in the tissue and is refer-
red to as ATP. The intracellular pH was determined from the
chemical shift (6) of the Pi relative to the PCr using the
following equation: pH = 6.75 + log [(6-3.27)/(5.69-6)],
(Gadian et al., 1983). Initial experiments under different nut-
ritional conditions using both in vivo (NMR) and in vitro
(HPLC) techniques confirmed that the 3'P-NMR signal
represented tumour tissue metabolism and that possible sig-
nals from other host tissues could be neglected even in small
tumours. Thus, a PCr/ATP ratio of 1.5 ± 0.3 (HPLC) and
1.6 ± 0.6, (NMR) was calculated for tumour tissue. For
skeletal muscle the PCr/ATP ratio was 3.1 ± 0.8; P<0.01.
High performance liquid chromatography (HPLC)
Non necrotic parts of tumour tissue were rapidly obtained by
surgical dissection and frozen in liquid nitrogen and freeze-
dried for 8 h (LYOVAC GT 2, Leybold-Heraeus). Tumour
tissue was then minced to a powder. To 15 mg dry powder
0.285 ml PCA (1.5 mM) containing 1 M EDTA was added
and the extraction was performed by gentle agitation for
20 min on ice. The precipitate was separated by centrifuga-
tion and neutralised before injection into the HPLC (Phar-
macia Fine Chemicals AB, Uppsala, Sweden) (Idstrom et al.,
1990). The column used was a prepacked reversed phase
C2/C18 Silca Column, Mino RPC S5/20 (5 rm;
4.6 x 200mm), (Pharmacia). The eluation medium mobile
phase consisted of 0.1 M ammonium dihydrogen phosphate
buffer (NH4H2PO4) with pH adjusted to 6.0 with 3 M
ammonium hydroxide. The nucleotides, nucleosides, and
purine bases, adenosinetriphosphate (ATP), adenosine
diphosphate (ADP), adenosine monophosphate (AMP),
inosine monophosphate (IMP), inosine (In), hypoxantine
(Hx) and uric acid (Ua) as well as phosphocreatine (PCr) and
creatine (Cr), were separated and concentrations were deter-
mined as described in details elsewhere (Soussi et al., 1990).
The energy charge was calculated according to Atkinson
(Atkinson, 1977):
EC = ([ATP] + 1/2[ADP])/([ATP] + [ADP] + [AMP])
Incorporation ofbromodeoxyuridine (BrdUrd)
The method for BrdUrd incorporation into tumour DNA is
described in detail elsewhere (Van Furth & Van Zwet, 1988;
Sasaki et al., 1986; Gratzner, 1982). Briefly, the incorporation
of BrdUrd was accomplished by an i.p. injection of
0.1 mg g-' bw BrdUrd dissolved in 0.9% NaCl, one hour
before sacrifice (Wilson et al., 1985). Tumour tissue was
rapidly excised after sacrifice and washed with phosphate
buffered saline (PBS). A single cell suspension was accomp-
lished by cutting the tumour tissue into small pieces with a
scalpel and then using collagenase (1 mg ml-') in buffer solu-
tion. The mixture was then stirred with a magnetic follower
for 10 min. The cell viability was around 95% as controlled
by the trypan blue exclusion test before further analysis
(Berry, 1974). The cell suspension was then centrifuged on to
a slide using a cytocentrifuge an adequately dense monolayer
of cells. Final preparation was then performed and
immunoperoxidase-conjugated anti-BrdUrd exposed by
diaminobenzidine (DAB) added and counterstained with
Mayer. The percentage labelled cells indicated by BrdUrd
incorporation into DNA was calculated from a total of 500
counted cells on each slide.
Experiment 1: Energy state in tumour tissue during tumour
progression
In this experiment the animals were investigated on day 7, 9,
13 and 15. A spectrum of the tumour was obtained by
3'P-NMR spectroscopy for in vivo analysis of the tumour
energy state (Glickson et al., 1987; Koutcher & Tyler 1984;
Ng et al., 1982; Rosen & Brady, 1983; Wehrle & Glickson,
1986). The tumour became palpable on day 5-6 and weighed
around 0.5 g at this time point. Complete growth curves of
the tumour have been published elsewhere (Karlberg et al.,
1981).
Experiment 2: Energy state in tumour tissuefollowing
starvation and refeeding
Animals were fed ad libitum until day 9 following tumour
implantation. They were then starved with free access to
water for 24 h followed by a 10 h refeeding period. The
animals were anaesthetised and analyses were performed
immediately before starvation 'freely-fed', after starvation
'starved' and after refeeding 'refed'. This protocol was used
for both in vivo (3'P-NMR) and in vitro (HPLC) studies on
the tumour bioenergetic status. Tumour tissue samples were
also taken for measurement of Brd Urd incorporation into
DNA.
Experiment 3: Energy state in tumour tissue after
alpha-difluoromethylornithine (DFMO) administration
DFMO (MDL 71.782), a specific inhibitor of the enzyme
ornithinedecarboxylase (ODC) (Pegg, 1988; Mamon et al.,
1976), was kindly supplied by Merrel-Dow Research Ins-
titute, Strasbourg, France. This compound was diluted in tap
water (2%) and given continuously to the animals in drink-
ing water from day 3 until day 9 when the animals were
anaesthetised and studied in vivo (3'P-NMR). Mice consumed
4-5 ml of water per mouse per day. A parallel group of
animals were killed following the NMR experiments for in
vitro determinations (HPLC) of the tumour energy state.
Statistics
Differences between two groups were compared by the
Student's t-test. One factor factorial ANOVA with or with-
out repeated measures was used for multiple group com-
parisons. Results are given as mean ± SE; a 95% confidence
interval was used in ANOVA computations; P<0.05 is con-
sidered as statistically significant.
Results
Nutritional alterations
Twenty-four hours starvation reduced animal weight from
22.2 ± 0.4 g to 18.0 ± 0.4 g. Subsequent refeeding for 10 h
resulted in weight gain to 19.8 ± 0.4 g. The mean tumour
weight during starvation/refeeding was 1.3 ± 0.2 g,
1.2 ± 0.2 g and 1.7 ± 0.1 g (P<0.05) respectively recorded in
'Experiment 2', indicating that tumour growth was arrested
during the starvation period and was then reinitiated during
refeeding as reported earlier (Westin et al., 1991a; Westin et
al., 1991b).
DFMO treatment (Experiment 3) by addition of 2%
difluoromethylornithine to the drinking water caused a
significant decrease in tumour weight, which was 1.5 ± 0.1 g
in non-treated tumour animals compared to 1.0 ± 0.2 g in664 T. WESTIN et al.
DFMO treated animals (P<0.05). There was, no significant
difference in carcass weight (22.3 ± 0.5 g and 22.1 ± 0.6 g)
between the two groups. There was no influence on water
and food intake by DFMO. The tumour concentration of
putrescine and spermidine decreased, while spermine concent-
ration was unchanged by DFMO as reported elsewhere
(Westin et al., 1991b).
Tumour energy state
The energy state of the tumour was assessed by 3'P-NMR (in
vivo) during tumour growth (Experiment 1), (Table I and
Figure 2). The tumour was analysed with a size of 0.5-1 g
on day 7 until a size of 4-6 g on day 15 just prior to animal
death due to the tumour. During tumour progression the
ATP/Pi and PCr/Pi were slightly reduced while the PME and
the PDE levels were increased (Figure 2). There was no
significant change in the tumour pH during tumour progres-
sion. Table II contains data from in vivo (3'P-NMR) deter-
minations and Table III contains in vitro (HPLC) determina-
tions of energy rich phosphates in tumour tissue following
24 h starvation and subsequent 10 h refeeding and following
DFMO treatment of tumour-bearing animals. The energy
charge in tumour tissue decreased significantly during starva-
tion and returned to normal tumour levels during refeeding.
The PCr/Pi and the ATP/Pi were reduced, although the
reductions did not reach statistical significance during starva-
tion. Subsequent refeeding resulted in a significant overshoot
of these phosphates compared to levels in tumour tissue from
freely-fed animals. Inorganic phosphate decreased during
refeeding. In vivo 31P-NMR and in vitro determinations gave
qualitatively comparable results (Table II vs III). Thus, light
pentobarbital anaesthesia had no effect on tumour content of
high energy phosphates, (the in vitro determination of phos-
phates was done without prior use of anaesthesia).
Starvation/refeeding was associated with alterations in
tumour blood flow (Figure 1).
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Figure 1 Tumour blood flow in animals that were freely fed,
then subjected to a period of 10 h complete starvation, and then
refed again for 4 h. The decline in blood flow was significant at
P<0.05. Blood flow was measured as described in Material and
methods.
Table I Energetic parameters in tumour tissue measured by in vivo 3'P-NMR during
tumour progression. Measurements were repeated on day 7-15 in the same animals (n = 6);
values are mean ± s.e. The tumour weight was 0.5-I g day 7 and 4-6 g day 15
ANOVA
Day 7 9 13 1S
PME 3.7 0.2 6.0 0.6 4.5 +0.4 14.4 3.8 0.05
Pi 9.6 ± 0.1 13.1 + 1.0 9.5 ± 0.7 25.9 ± 7.2 0.05
PDE 9.1 ±0.9 18.7 1.6 9.6 1.7 14.2 1.4 0.05
PCr 25.3 + 1.0 16.0 + 2.1 18.4 ± 0.5 10.0 ± 0.6 0.01
ATP 9.5 1.0 7.4± 1.2 8.0 0.2 5.9± 1.6
pH 7.3 0.02 7.1 ±0.04 7.2 0.04 7.2 0.01
PCr/Pi 2.6±0.5 1.4±0.3 2.0±0.1 0.6±0.1 0.01
ATP/Pi 1.0±0.1 0.5±0.1 0.9±0.1 0.4±0.1 0.01
One factor ANOVA for repeated measures was used for the statistical evaluation.
Metabolite levels are in per cent of total phosphorus content as described in Materials and
methods.
Table II Energetic parameters assessed in vivo on day 9 by 3'P-NMR in tumour-bearing
(TB) mice that were either freely-fed (n = 9), starved for 24 h (n = 10) and subsequently
refed for 10 h (n = 5) or freely-fed DFMO-treated (n = 5); values are mean ± s.e.
Freely-fed
Freely-fed Starved Refed TB-animals ANOVA
TB-animal TB-animal TB-animal receiving DFMO P <
PME 4.2 ± 0.8 6.7 ± 2.6 1.3 ± 0.7 2.6 ± 1.4
Pi 8.4 1.8 11.0 o 2.9b 1.3 0.3 3.4 0.4 0.05
PDE 12.4±2.5 9.9 1.5 5.2 1.7a 6.0 1.2
PCr 19.3 1.2 18.3 2.6 22.3 1.7 30.2 6.7a 0.05
ATP 11.3±2.9 13.5±2.2 16.1 2.3 19.0± 1.3 0.08
pH 7.1 ±0.1 6.9±0.2 7.2 0.1 7.2±0.1
PCr/Pi 5.8 2.4 3.4 ±l.lb 23.7 6.3a 9.4 2.1 0.0004
ATP/Pi 5.7 ± 3.0 2.6 ± 09.b 16.9 4.9a 6.3 ± 1.4 0.008
One factor factorial ANOVA was used for the statistical evaluation. aSignificantly different
(P <0.05) vs freely-fed and starved TB-animals. bSignificantly different (P <0.05) vs refed
TB-animals.
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Table III HPLC analysis of phosphocreatine, creatine, nucleotides, nucleosides and purine bases in
tumour biopsy specimens from either tumour-bearing (TB) mice (on day 9) that were freely-fed
(n = 8), starved for 24 h (n = 6) subsequently refed for 10 h (n = 6) or freely-fed DFMO-treated
(n = 5). The results can be compared to in vivo measurements in Table II, which were done before the
animals were killed. Values are mean ± s.e. and are expressed as 1imolg-I dry weight
Freely-fed
Freely-fed Starved Refed TB-animals ANOVA
TB-animal TB-animal TB-animal receiving DFMO P <
Energy charge 0.61 ± 0.02 0.52 ± 0.03a 0.69 + 0.02a,b 0.65 ± 0.02 0.0008
ATP 4.6 ± 0.5 4.3 ± 0.6 7.3 + 0.8a,b 7.0 ± 1.6 0.007
ADP 3.4 ± 0.3 4.2 ± 0.3a 4.1 ± 0.2a 4.4 ± 0.3 0.05
AMP 2.2 ± 0.1 3.5 ± 0.3a 2.0 ± 0.2b 2.7 ± 0.5 0.001
IMP 2.0 0.1 2.9 ± O.la 1.5± 0.3b 2.4 ± 0.2 0.0002
Inosine 3.5 0.3 3.8 ± 0.2 3.8 ± 0.2 4.1 ± 0.2
Hypoxanthine 1.3 ± 0.1 1.6 ± 0.2 2.5 + 0 Ia,b 1.4 ± 0.4 0.0001
Uric acid 2.7 ± 0.2 2.2 ± 0.4 1.4 + 0.2a,b 1.4 ± 0.4 0.003
PCr 5.9 0.6 4.8 ± 0.6 4.0 ± 0.3a 11.9 ± 1.4 0.06
Cr 36.6 + 3.4 36.3 ± 6.1 37.1 ± 2.4 49.1 ± 2.6 0.03
One factor factorial ANOVA was used for the statistical evaluation. aSignificantly different
(P <0.05) vs freely-fed TB-animals. bSignificantly different (P <0.05) vs starved TB-animals.
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Figure 2 Time course of relative changes in PCr/Pi (0), ATP/Pi
(0) and in PME (A), in tumour tissue determined by in vivo
3'P-NMR spectroscopy in the same animals following tumour
implantation on day 0. The tumours become palpable and
anorexia starts on day 5-7 in tumour-bearing mice. Most
animals die spontaneously on day 17. Bars represent s.e. (n = 6).
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Figure 3 Relative change in ATP concentration in tumour tissue
during starvation - refeeding and following DFMO-treatment in
relation to DNA-synthesis in the tumour. Animals were starved
and refed or treated with DFMO (difluoro-methylornithine) as
described in Material and methods. Bars represent SE, n = 10 in
each group. The ATP was determined by HPLC (Table III).
DNA-synthesis was estimated by bromodeoxy-uridine (BrdUrd)
incorporation into tumour cell DNA. *P<0.05 vs ad lib (freely-
fed tumour-bearing animals).
DFMO treatment (Experiment 3) caused a significant rise
in the high energy phosphates (PCr, P<0.05 and ATP,
P<0.08) measured both in vivo and in vitro. There was no
significant difference in either pH or energy charge
(0.63 ± 0.06) in DFMO-treated tumour-bearing groups com-
pared to untreated control TB-animals (Tables II and
III).
Tumour DNA synthesis
Acute starvation decreased BrdUrd incorporation into DNA
by 20% (P <0.01) and this attenuation was restored during
subsequent refeeding. DFMO treatment decreased DNA-
synthesis in tumour tissue (Figure 3).
Discussion
Previous experiments in our tumour model have demon-
strated that the carbohydrate component in a standard chow
diet initiates tumour DNA synthesis during refeeding which
was probably not related to insulin (Westin et al., 1991a).
The aim of this study was, therefore, to evaluate whether
food intake and acute starvation modulate tumour growth
and DNA synthesis indirectly by rapid alterations in the
energy state of the tumour, since ATP and ADP are impor-
tant elements in allosteric regulation of glycolysis and res-
piration. Polyamine synthesis inhibition was used as an alter-
native approach to decrease tumour DNA synthesis and
thereby indirectly energy rich phosphates.
Our results demonstrate that the energy charge was
significantly decreased in tumours on starved animals, while
it rapidly returned to pre-starvation levels during refeeding.
These findings confirm that the metabolism in rapidly grow-
ing experimental tumours are sensitive to acute changes in
the host nutrition state. A nutrition related growth-
phenomenon in experimental tumours has also been illus-
trated indirectly by giving tumour-bearing rats intravenous
nutrition, which resulted in a more rapid tumour growth
compared to orally nourished tumour-bearing animals with
anorexia (Torosian, 1984). By this mechanism anorexia may
be a counter-regulatory phenomenon to slow down tumour
growth and thereby maximise survival. The present study
suggests that nutrition-induced alterations in tumour growth
are in part explained by alterations in tumour content of
energy phosphates, probably related to a reduced tumour
blood flow.
We have recently demonstrated that a decrease in DNA
synthesis following starvation was preceded by a similar
change in tumour ornithine-decarboxylase activity (ODC),
(Westin et al., 1991b). ODC-activity can be irreversibly666 T. WESTIN et al.
inhibited by DFMO (difluoro-methyl-ornithine), a substance
which is under clinical evaluation for tumour treatment. In
present experiments DFMO inhibited tumour growth as
expected (Pegg, 1988), as confirmed by a lower BrdUrd
incorporation into DNA and a 35% decrease in tumour
mass. It is important to emphasise that food intake was not
decreased in DFMO-treated tumour-bearing animals.
Therefore, we conclude that DFMO-inhibition of tumour
growth was direct rather than indirect by altered nutrition
and decreased availability of energy phosphates. In line with
this theory, both ATP and PCr levels were increased and Pi
decreased in tumour tissue during DFMO-inhibition of
tumour growth. Therefore, we did not measure tumour blood
flow in DFMO treated animals, since they did not show a
decline in tumour high energy phosphates.
The energy charge in tumour tissue was under all condi-
tions significantly lower than 0.85, which suggests a different
equilibrium for energy production/utilisation in tumour tissue
than seen in normal tissues (Atkinson, 1977). This is not to
say that the metabolic rate was high in our tumours, but may
rather represent a different equilibrium for energy flow com-
pared to normal cells. We have previously confirmed that
respiration and glycolysis is lower in these tumour cells than
found in many normal cells (unpublished results). The overall
tumour concentration of the high-energy phophates was also
lower than seen in most normal tissues. This may to some
extent depend on the fact that tumour tissue is composed of
a mixture of cells with high and low viability. Another
explanation may be that tumour profusion is heterogeneous
and that tumour blood flow was considerably lower than
found in normal tissues as liver and skeletal muscles (unpub-
lished). Blood flow is the major determinant of substrate and
oxygen supply to the tissue. Insufficient tumour perfusion
implicates poor substrate supply and low oxygen concentra-
tion which probably affects the tumour by reducing its
energy state. Therapy induced decreases in the nucleotide
triphosphates-to-Pi ratio have been attributed to decreased
blood flow (Evelhoch et al., 1988). However, necrosis will
occur only when the ATP is depleted to monophosphates
and further irreversibly degraded to nonphosphorylated pro-
ducts. In a study investigating the effects of the cytokine
interleukin-a on RIF-1 tumours, necrosis appeared at least
12 h after an important reduction in phosphate metabolites
(Constantinidis et al., 1989).
Our findings of high energy phosphates in tumour tissue
agree with previous results obtained by NMR spectroscopy
on human (Daly & Cohen, 1989; Vaupel et al., 1989) and
experimental tumours (Smith et al., 1989). Major increases in
Pi compared with the other phosphate resonances have been
shown to be a result of tumour necrosis (Naruese et al.,
1985). The PME levels found to increase with tumour pro-
gression support the usefulness of this 31P NMR signal in
monitoring tumour energetics. However, any AMP, IMP and
sugar-phosphates formed would also contribute to the PME
peak which contains contributions from phos-
phoethanolamine and phosphocholine. It should be pointed
out that a direct comparison between the HPLC and the
NMR data could be misleading since analysis of tissue ext-
racts reflects total metabolite concentrations and not free
cytosolic contents as by in vivo NMR. The PCr instability
and its rapid breakdown to Pi and Cr is not avoidable in
biochemical analysis. However, assessing this metabolite in
vivo by NMR may correct for the usually lower extract
values.
In conclusion, this study gives support to a direct role of
ODC for induction or promotion of tumour cell division. A
decrease in ODC-activity by DFMO (Pegg, 1988) led to
inhibition of DNA-synthesis, but this decrease was not
explained by a decreased availability of cellular energy. On
the contrary, a lowered DNA synthesis following ODC-
inhibition by DFMO was associated with a rise in tumour
energy rich phosphates probably secondary to a decreased
energy demand for cell division. In contrast, a fall in DNA
synthesis following starvation led to a decrease in tumour
energy content perhaps related to a lower blood flow. Our
findings give a rationale to suggest that force-feeding of
energy-deprived tumours may stimulate tumour growth pro-
vided appropriate tumour oxygenation (Vaupel et al., 1989).
In this respect carbohydrate containing diets may be most
detrimental (Westin et al., 1991a). In other words, force-
feeding by glucose may activate ODC, which may induce
DNA synthesis and thereby promote cell cycle traverse.
These events may then give a more susceptible situation for
cytocidal drug therapy. This hypothesis can now be
systematically tested in experimental and clinical tumour
systems.
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